HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Olca Basturk Selected Research

Olca Basturk Research Topics

Disease

58Neoplasms (Cancer)
01/2024 - 06/2004
20Adenocarcinoma
06/2023 - 01/2009
20Carcinoma (Carcinomatosis)
05/2023 - 06/2004
13Pancreatic Neoplasms (Pancreatic Cancer)
02/2024 - 03/2010
8Neoplasms, Cystic, Mucinous, and Serous
01/2022 - 10/2005
6Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2023 - 03/2015
6Carcinogenesis
01/2022 - 10/2005
3Cholecystitis
08/2023 - 08/2011
3Inflammation (Inflammations)
01/2023 - 12/2015
3Cysts
01/2022 - 10/2005
3Carcinoma in Situ
07/2021 - 03/2011
3Polyps
03/2021 - 01/2020
2Medullary Carcinoma
01/2023 - 11/2020
2Neuroendocrine Carcinoma
01/2023 - 11/2019
2Gallbladder Neoplasms (Gallbladder Cancer)
01/2022 - 08/2012
2Adenoma (Adenomas)
01/2022 - 10/2005
2Fibrosis (Cirrhosis)
01/2021 - 08/2011
2Metaplasia
01/2021 - 01/2020
2Acinar Cell Carcinoma
10/2017 - 03/2015
2Neoplasm Metastasis (Metastasis)
02/2015 - 01/2014
2Mucinous Adenocarcinoma (Mucinous Carcinoma)
02/2015 - 03/2010
2Serous Cystadenoma
03/2011 - 02/2006
1Colorectal Neoplasms (Colorectal Cancer)
01/2024
1Wounds and Injuries (Trauma)
08/2023
1Acute Cholecystitis
08/2023
1Necrosis
01/2023
1Residual Neoplasm
12/2022
1Ganglioneuroma
03/2022
1Neuroma
03/2022
1Cystadenocarcinoma
01/2022
1Cystadenoma
01/2022
1Choledochal Cyst (Choledochal Cysts)
01/2022
1Hamartoma
01/2022
1Gallstones (Gallstone)
01/2022
1Malignant Mesothelioma
01/2021
1Cholangitis
01/2021
1Hyperplasia
01/2021
1Liver Neoplasms (Liver Cancer)
01/2021
1Mesothelioma
01/2021
1Peritoneal Diseases
01/2021
1Pulmonary Embolism
12/2020
1Disease Progression
12/2020
1Paraganglioma (Paragangliomas)
09/2020
1Fibrolamellar hepatocellular carcinoma
01/2020
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2020

Drug/Important Bio-Agent (IBA)

13MucinsIBA
01/2023 - 07/2004
5Proteins (Proteins, Gene)FDA Link
01/2024 - 01/2015
5RNA (Ribonucleic Acid)IBA
06/2023 - 11/2018
4DNA (Deoxyribonucleic Acid)IBA
01/2024 - 01/2017
4Biomarkers (Surrogate Marker)IBA
03/2022 - 01/2014
4Glycoproteins (Glycoprotein)IBA
01/2021 - 10/2005
4Colloids (Colloid)IBA
04/2016 - 07/2004
3CholesterolIBA
03/2021 - 01/2020
3AlbuminsIBA
01/2020 - 08/2016
3Keratins (Keratin)IBA
01/2020 - 10/2005
3ParaffinIBA
11/2018 - 01/2016
3CAM 5.2 antigenIBA
07/2017 - 06/2004
3amsonic acid (DAS)IBA
11/2016 - 03/2010
2VaccinesIBA
01/2024 - 06/2023
22-toluenesulfonamide (OTS)IBA
01/2022 - 02/2015
2EnzymesIBA
01/2022 - 03/2017
2Bile Pigments (Bilin)IBA
07/2021 - 01/2021
2MicroRNAs (MicroRNA)IBA
03/2021 - 01/2014
2Oncogene Proteins (Oncogene Protein)IBA
01/2021 - 10/2005
2CateninsIBA
01/2021 - 11/2016
2LipidsIBA
09/2020 - 02/2006
2Cadherins (E-Cadherin)IBA
05/2020 - 11/2005
2ChromatinIBA
01/2020 - 11/2019
2Messenger RNA (mRNA)IBA
01/2020 - 08/2016
2Formaldehyde (Formol)FDA Link
11/2018 - 01/2016
2AntigensIBA
11/2017 - 08/2016
2Mucin-1 (CA 15-3 Antigen)IBA
07/2017 - 12/2011
2AntibodiesIBA
03/2017 - 11/2016
2Phenobarbital (Luminal)FDA Link
10/2016 - 11/2012
2Hormones (Hormone)IBA
10/2016 - 01/2014
2Immunoglobulin G (IgG)IBA
06/2011 - 11/2005
2Indicators and Reagents (Reagents)IBA
10/2010 - 03/2009
1Eosine Yellowish-(YS) (Eosin)IBA
12/2022
1N-acetyltalosaminuronic acid (NAT)IBA
12/2022
1phytobacteriomycin (PBM)IBA
01/2022
1Epithelial Cell Adhesion MoleculeIBA
04/2021
1Cre recombinaseIBA
01/2021
1B72.3 antibodyIBA
01/2021
1trisacryl gelatin microspheresIBA
01/2021
1Calbindin 2IBA
01/2021
1Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
12/2020
1Aurora Kinase AIBA
12/2020
1ENMD 2076IBA
12/2020
1LigandsIBA
11/2020
1Protein Kinases (Protein Kinase)IBA
01/2020
1VimentinIBA
01/2020
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2019
1pazopanibFDA Link
10/2018

Therapy/Procedure

14Therapeutics
02/2024 - 10/2005
10Pancreaticoduodenectomy
10/2021 - 01/2009
8Cholecystectomy
08/2023 - 08/2011
5Neoadjuvant Therapy
12/2022 - 09/2016
4Pancreatectomy
01/2022 - 06/2004
2Precision Medicine
01/2019 - 08/2012
1Immunotherapy
01/2024